Results 231 to 240 of about 1,155,184 (279)
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Towards accurate malnutrition identification in individuals with Spinal Cord Injury: a qualitative investigation. [PDF]
Keenan SJ +3 more
europepmc +1 more source
[Juvenile idiopathic arthritis-persistent oligoarticular subtype : Consensus-based treatment recommendations as part of the ProKind Rheuma Initiative]. [PDF]
Peitz J +6 more
europepmc +1 more source

